MX379000B - Proceso para preparar inhibidores de tirosina cinasa de bruton (btk). - Google Patents

Proceso para preparar inhibidores de tirosina cinasa de bruton (btk).

Info

Publication number
MX379000B
MX379000B MX2019005527A MX2019005527A MX379000B MX 379000 B MX379000 B MX 379000B MX 2019005527 A MX2019005527 A MX 2019005527A MX 2019005527 A MX2019005527 A MX 2019005527A MX 379000 B MX379000 B MX 379000B
Authority
MX
Mexico
Prior art keywords
preparing
btk
tyrosine kinase
inhibitors
bruton tyrosine
Prior art date
Application number
MX2019005527A
Other languages
English (en)
Other versions
MX2019005527A (es
Inventor
Alec Fettes
Alexander Gmehling
Danial Beaudry
Francis Gosselin
Haiming Zhang
Ngiap- Kie Lim
Qingping Tian
Stephan Bachmann
Sushant Malhotra
Theresa Cravillion
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019005527A publication Critical patent/MX2019005527A/es
Publication of MX379000B publication Critical patent/MX379000B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • B01J31/2414—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom comprising aliphatic or saturated rings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/824—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se proporcionan métodos para preparar el compuesto inhibidor de tirosina cinasa de Bruton (``BTK´´) 2-{3'-hidroximetil-1-metil-5-[5-((S)-2-metil-4-oxetan-3-il-piperazin-1-il)-piridin-2-ilamino]-6-oxo-1,6-dihidro-[3,4']bipiridinil-2'-il}-7,7-dimetil-3,4,7,8-tetrahidro-2H,6H-ciclopenta[4,5]pirrolo[1,2-a]pirazin-1-ona. También se proporcionan métodos para preparar compuestos de lactama tricíclica.
MX2019005527A 2016-12-15 2017-12-13 Proceso para preparar inhibidores de tirosina cinasa de bruton (btk). MX379000B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662434569P 2016-12-15 2016-12-15
PCT/EP2017/082723 WO2018109050A1 (en) 2016-12-15 2017-12-13 Process for preparing btk inhibitors

Publications (2)

Publication Number Publication Date
MX2019005527A MX2019005527A (es) 2019-08-12
MX379000B true MX379000B (es) 2025-03-10

Family

ID=61007648

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019005527A MX379000B (es) 2016-12-15 2017-12-13 Proceso para preparar inhibidores de tirosina cinasa de bruton (btk).
MX2020012097A MX386843B (es) 2016-12-15 2017-12-13 Proceso para preparar inhibidores de tirosina cinasa de bruton (btk)

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020012097A MX386843B (es) 2016-12-15 2017-12-13 Proceso para preparar inhibidores de tirosina cinasa de bruton (btk)

Country Status (17)

Country Link
US (4) US10385058B2 (es)
EP (3) EP3825317A3 (es)
JP (2) JP6800334B2 (es)
KR (2) KR102257159B1 (es)
CN (2) CN110446710B (es)
AR (2) AR110357A1 (es)
AU (4) AU2017376580B2 (es)
CA (2) CA3039090C (es)
ES (1) ES2894262T3 (es)
HR (1) HRP20211553T1 (es)
IL (2) IL284690B (es)
MX (2) MX379000B (es)
PL (1) PL3555099T3 (es)
SG (2) SG10202009148XA (es)
SI (1) SI3555099T1 (es)
TW (3) TWI766176B (es)
WO (1) WO2018109050A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3555099T1 (sl) 2016-12-15 2021-11-30 F. Hoffmann-La Roche Ag Postopek priprave zaviralcev BTK
CN111741959B (zh) * 2018-02-19 2023-09-05 广州麓鹏制药有限公司 Btk的抑制剂及其突变体
US12637467B2 (en) 2019-02-25 2026-05-26 Newave Pharmaceutical Inc. Inhibitor of BTK and mutants thereof
US20210221792A1 (en) * 2020-01-16 2021-07-22 Hanmi Pharm Co., Ltd. Convergent synthesis of poziotinib derivative
CA3171012A1 (en) 2020-02-20 2021-08-26 Hutchison Medipharma Limited Heteroaryl heterocyclic compounds and uses thereof
CN115715291B (zh) * 2020-06-18 2025-04-29 上海华汇拓医药科技有限公司 布鲁顿酪氨酸激酶抑制剂及其制备方法
EP4214206B1 (en) * 2020-09-21 2026-08-12 HUTCHMED Limited Heteroaryl heterocyclic compounds and uses thereof
WO2022206924A1 (zh) * 2021-04-02 2022-10-06 南京明德新药研发有限公司 含氮三并环双功能化合物及其制备方法和应用
ES3012969T3 (en) * 2021-05-05 2025-04-10 Hoffmann La Roche Process for preparing btk inhibitors
CN117500806A (zh) * 2021-05-28 2024-02-02 默沙东有限责任公司 Btk抑制剂及其中间体的合成
CN113603685A (zh) * 2021-07-23 2021-11-05 都创(上海)医药开发有限公司 Fenebrutinib化合物的晶型及其制备方法和用途
WO2026017823A1 (en) 2024-07-18 2026-01-22 F. Hoffmann-La Roche Ag Process for preparing btk inhibitor intermediates

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
US7432375B2 (en) * 2003-03-06 2008-10-07 Eisai R & D Management Co., Ltd. JNK inhibitors
AU2006229995A1 (en) * 2005-03-25 2006-10-05 Glaxo Group Limited Process for preparing pyrido(2,3-d)pyrimidin-7-one and 3,4-dihydropyrimido(4,5-d)pyrimidin-2(1H)-one derivatives
NZ584279A (en) 2007-09-19 2011-11-25 4Sc Ag Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
JP5469604B2 (ja) * 2007-09-19 2014-04-16 4エスツェー アクチェンゲゼルシャフト 新規テトラヒドロ融合ピリジン
CN101781312B (zh) * 2009-12-30 2012-09-26 中国科学院广州生物医药与健康研究院 一种吲哚衍生物的合成方法
CA3034600C (en) * 2010-05-07 2020-11-10 Genentech, Inc. Pyridone and aza-pyridone compounds and methods of use
UA111756C2 (uk) * 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
US9076830B2 (en) * 2011-11-03 2015-07-07 Applied Materials, Inc. Robot systems and apparatus adapted to transport dual substrates in electronic device manufacturing with wrist drive motors mounted to upper arm
TW201326171A (zh) * 2011-11-03 2013-07-01 Genentech Inc 烷基化哌□化合物
CA2852964A1 (en) * 2011-11-03 2013-05-10 F. Hoffmann-La Roche Ag Bicyclic piperazine compounds
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
TW201427970A (zh) * 2012-10-12 2014-07-16 Univ Health Network 激酶抑制劑及使用其治療癌症的方法
KR20150135332A (ko) * 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
TWI513371B (zh) * 2013-07-08 2015-12-11 Lextar Electronics Corp 整合無線暨有線的照明控制系統
CN105793251B (zh) * 2013-12-05 2018-10-12 豪夫迈·罗氏有限公司 具有亲电子官能性的杂芳基吡啶酮和氮杂-吡啶酮化合物
TWI659019B (zh) * 2014-02-28 2019-05-11 日商帝人製藥股份有限公司 吡唑醯胺衍生物
DE102015206627A1 (de) 2014-07-09 2016-01-28 Siemens Aktiengesellschaft Selbstsichernder Umrichter
WO2016050921A1 (en) * 2014-10-02 2016-04-07 F. Hoffmann-La Roche Ag Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
SG11201704808VA (en) * 2014-12-18 2017-07-28 Principia Biopharma Inc Treatment of pemphigus
CN107614503B (zh) * 2015-04-29 2020-03-10 广东众生药业股份有限公司 稠环或三环芳基嘧啶化合物用作激酶抑制剂
PL4049660T3 (pl) * 2016-02-29 2025-06-09 F. Hoffmann-La Roche Ag Kompozycje postaci dawkowania zawierające inhibitor kinazy tyrozynowej Brutona
SI3555099T1 (sl) 2016-12-15 2021-11-30 F. Hoffmann-La Roche Ag Postopek priprave zaviralcev BTK

Also Published As

Publication number Publication date
AR110357A1 (es) 2019-03-20
KR20210002122A (ko) 2021-01-06
ES2894262T3 (es) 2022-02-14
CA3039090A1 (en) 2018-06-21
US20200062762A1 (en) 2020-02-27
TWI766176B (zh) 2022-06-01
AU2017376580B2 (en) 2020-08-13
US20180230155A1 (en) 2018-08-16
AU2020201261A1 (en) 2020-03-12
EP3825317A3 (en) 2021-07-28
EP3555099A1 (en) 2019-10-23
KR20190077090A (ko) 2019-07-02
AU2021201052A1 (en) 2021-03-11
BR112019011247A2 (pt) 2019-10-15
IL284690A (en) 2021-08-31
EP3555099B1 (en) 2021-08-18
PL3555099T3 (pl) 2021-12-27
EP4574828A3 (en) 2025-09-24
SG10201913918UA (en) 2020-03-30
CN110446710B (zh) 2022-08-02
EP4574828A2 (en) 2025-06-25
CA3104116A1 (en) 2018-06-21
AU2017376580A1 (en) 2019-03-21
EP3825317A2 (en) 2021-05-26
MX2019005527A (es) 2019-08-12
CN111333656A (zh) 2020-06-26
JP6800334B2 (ja) 2020-12-16
JP7153705B2 (ja) 2022-10-14
SG10202009148XA (en) 2020-10-29
AU2020201261B2 (en) 2020-11-19
KR102375771B1 (ko) 2022-03-17
CN110446710A (zh) 2019-11-12
JP2021042228A (ja) 2021-03-18
WO2018109050A1 (en) 2018-06-21
IL265067B (en) 2021-07-29
TWI673271B (zh) 2019-10-01
MX2020012097A (es) 2021-10-06
SI3555099T1 (sl) 2021-11-30
TW201827433A (zh) 2018-08-01
US11661424B2 (en) 2023-05-30
AU2020201260B2 (en) 2020-11-05
AR126445A2 (es) 2023-10-11
CA3039090C (en) 2023-09-19
AU2020201260A1 (en) 2020-03-12
JP2019535784A (ja) 2019-12-12
IL284690B (en) 2022-07-01
KR102257159B1 (ko) 2021-05-28
US20210079004A1 (en) 2021-03-18
US10385058B2 (en) 2019-08-20
CA3104116C (en) 2026-05-26
TW201940489A (zh) 2019-10-16
US10882864B2 (en) 2021-01-05
US20230250103A1 (en) 2023-08-10
MX386843B (es) 2025-03-19
TW201938565A (zh) 2019-10-01
HRP20211553T1 (hr) 2021-12-24
CN111333656B (zh) 2023-03-14

Similar Documents

Publication Publication Date Title
MX386843B (es) Proceso para preparar inhibidores de tirosina cinasa de bruton (btk)
IL277576A (en) Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
IL265918B (en) Converted pyrazolo[1,5–a]pyridine compounds as ret kinase inhibitors
ZA201800771B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
WO2017108723A3 (en) PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
IL270134B (en) A process for the preparation of compounds 3,2-dihydrothiazolo[2,3-a]pyrimidine-4-threat optical activity
EA201791066A1 (ru) Твердые формы ингибитора ask1
CL2011001947A1 (es) Compuestos derivados de fenil-{1,2,4}triazolo[1,5-a]piridin-fenilamino sustituidos, inhibidores de cinasa; utiles para tratar trastornos asociados con la permeabilidad vascular.
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
MX2019007339A (es) Compuestos de pirazolopirimidina y metodos de uso de los mismos.
MX2023012960A (es) Proceso para preparar inhibidores de btk.
IL267801B1 (en) Process for the preparation of 3-disubstituted 5-amino-h6-thiazolo[5,4-d]pyrimidine-7,2-dione compounds
MA46690A (fr) Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
PH12020551465A1 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
ZA201804871B (en) Process for preparing 7h-pyrrolo [2, 3-d] pyrimidine compounds
EP3808728A4 (en) PROCESS FOR THE PREPARATION OF 3(4),8(9)-BISFORMYLTRICYCLO[5.2.1.0²,6]DECANE
MA46463A (fr) Composés de pyrazolo[1,5-a]pyridine substitués en tant qu'inhibiteurs de la kinase ret